Navigation Links
EntreMed Secures $5.1 Million in Registered Direct Offering and Enters into Agreement for Rights to License ENMD-2076 in China
Date:9/8/2010

ROCKVILLE, Md., Sept. 8 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company focused on the development of ENMD-2076, its proprietary Aurora A/angiogenic kinase inhibitor for the treatment of cancer, today announced that on September 7, 2010 it entered into a securities purchase agreement with a group of strategic investors for gross proceeds of approximately $5.1 million.  The Company expects to complete the offering on or about September 8, 2010.  The financing will provide capital to fund operations through 2011 and enable the Company to move forward with expansion of development plans for ENMD-2076, which is currently in Phase 1 and Phase 2 clinical trials.  The ongoing Phase 2 trial of ENMD-2076 in ovarian cancer patients continues on track and the Company looks forward to the presentation of data early in 2011.

(Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO)

The investor group was led by Tak W. Mak, Ph.D., Director of The Campbell Family Institute for Cancer Research, and includes scientific advisors to EntreMed as well as experienced investors who have expertise both in oncology drug development and in drug development in the China markets. Concurrent with the execution of the securities purchase agreement, EntreMed entered into a rights agreement with Selected Value Therapeutics I, LLC (SVT) pursuant to which SVT has an option to exercise, on behalf of the investors, certain license, development and commercialization rights for ENMD-2076 in China, enabling the Company to leverage the experience and access that these investors have in this growing market.  If the option is exercised, EntreMed will be entitled to receive development milestone payments and royalties on future product sales within the geographic market. Th
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
2. EntreMed Reports Second Quarter 2010 Financial Results
3. EntreMeds ENMD-2076 Active in Solid and Hematological Cancers
4. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
5. EntreMed Presents Initial Clinical Results for ENMD-2076
6. EntreMed Receives New Patent for 2-Methoxyestradiol Analogs
7. EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting
8. EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR Annual Meeting
9. EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting
10. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
11. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)...  Perrigo Company plc ("Perrigo" or the "Company") (NYSE: ... offer from Mylan NV ("Mylan") (NASDAQ: MYL ) ... for $60.00 per share in cash and 2.2 Mylan ... The Board previously concluded that Mylan,s ... Company and its future growth prospects and was not ...
(Date:4/24/2015)... , April 24, 2015  IGI Laboratories, Inc. (NYSE ... based specialty generic pharmaceutical company, announced the Company will ... Tuesday, April 28, 2015 to discuss the 1st quarter ... listen to the call by dialing 1-888-346-3479. International participants ... should ask to be joined into the IGI Laboratories, ...
(Date:4/24/2015)...  Span-America Medical Systems, Inc. (NASDAQ:  SPAN) announced ... second quarter results on Thursday, April 30, after the ... will conduct a conference call at 10:00 a.m. ... financial and operating results for the second quarter ended ... conference call will be available online at ...
Breaking Medicine Technology:Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4
... Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX ), announced ... the Jefferies 2011 Global Healthcare Conference on June 9, 2011 ... The live and archived webcast of the company presentation can ... Center at www.idenix.com . Please log in approximately 5-10 ...
... 26, 2011 Hope Paige Designs, a company specializing in ... jewelry , will now be available in an additional 1,100 ... of pharmacies that carries its products to more than 1,800. ... medical alert jewelry and accessories, offering stylish key chains, necklaces, ...
Cached Medicine Technology:
(Date:4/26/2015)... Italian public health researchers have released new data ... and other asbestos-related industries. Surviving Mesothelioma has just posted ... to read it now. , University researchers ... Medicine analyzed more than 15,000 cases of mesothelioma between ... asbestos cancer was most common. , “Asbestos cement ...
(Date:4/26/2015)... (PRWEB) April 26, 2015 From March ... and his wife, Trivedi Master™ Dahryn Trivedi, spent a ... approved research laboratories and institutions in the efforts of ... medicine and nutraceutical supplements for human health care. ... different research labs and institutions. All lab facilities are ...
(Date:4/26/2015)... Rosa, CA (PRWEB) April 26, 2015 In ... from Washington State University evaluated the head-neck biomechanics occurring during ... of the study were able to determine that use of ... much as 3 to 5 times - more than when ... surprising outcome for such a study, but pointing out the ...
(Date:4/25/2015)... April 26, 2015 The National ... , a national endeavor to prepare nurses to provide ... a great success, according to a new report by ... original funding partners. , The project began in ... (CCP), under the direction of Elaine Tagliareni, EdD, RN, ...
(Date:4/25/2015)... The Hon. Ellen Tauscher, Independent Chair of the ... following the deadly earthquake in Nepal: , "Today a ... deaths of more than 1,000 people. The aftershocks ... India and other parts of South Asia. I ... of Nepal and the families of the victims. ...
Breaking Medicine News(10 mins):Health News:New Investigation Finds Mesothelioma “Clusters” Around Italian Cement Plants, According to Surviving Mesothelioma 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 2Health News:Hartford Foundation Report Details Success of NLN's Advancing Care Excellence for Seniors (ACE.S) Program 3
... Canadian television viewers will get,a chance to learn ... the,documentary "The Brain That Changes Itself" airs on the ... book of the same name by,author Norman Doidge, MD, ... and features the science, scientists, products and,customers of Posit ...
... Service Reductions , , WASHINGTON, Dec. ... Care (CQRC) -- an alliance of the country,s leading home oxygen ... oxygen beneficiaries -- are anxiously preparing for massive Medicare cuts to ... , , The Medicare Part ...
... feel better mentally, physically, researchers say , , WEDNESDAY, Dec. ... to work out their anger with exercise, a new ... otherwise healthy 7- to 11-year-olds found they reduced both ... a 10- to 15-week after-school aerobic exercise program. The ...
... Dec. 3 Many dentists and dental office,staff ... however, very,few dental professionals have taken advantage of ... while offering,the convenience of determining benefit information while ... "Paper submissions typically ...
... new release of HeartScore the interactive tool designed to ... and stroke in Europe created by the European Society ... 2008 at www.HeartScore.org . , This revised version ... patient data history and progress monitoring. Three formats are ...
... Dec. 3 New footage released today from an undercover ... staff deliberately violating the state,s mandatory reporting laws for sexual ... shows Lila Rose, a UCLA student journalist and ... 13-year-old girl. In an appointment with a Planned Parenthood nurse, ...
Cached Medicine News:Health News:Posit Science Featured in Canadian Documentary on the Brain 2Health News:Home Oxygen Community Braces for Massive Cuts to Medicare's Home Oxygen Benefit Starting January '09 2Health News:Home Oxygen Community Braces for Massive Cuts to Medicare's Home Oxygen Benefit Starting January '09 3Health News:Electronic Submission for Dental Predeterminations May Increase Efficiency, Patient Satisfaction 2Health News:The ESC launches a new release of HeartScore 2Health News:The ESC launches a new release of HeartScore 3Health News:Live Action: New Video Shows Indiana Planned Parenthood Covering Up Rape of 13-year old Girl 2
... The Surgifoam* absorbable gelatin sponge, U.S.P. ... gelatin absorbable sponge intended for hemostatic ... surface. The sponge is off-white and ... speed to hemostasis, highly favorable surgeon ...
12 mm diameter pigtail curved probes with eyes 4mm back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.9 inches....
The Meridian Microruptor V Nd: YAG laser system is indicated for posterior capsulotomy, peripheral iridotomy, and pupillary membranectomy procedures....
... method for determining color vision abnormalities and ... can be applied to many psychological and ... of four trays containing a total of ... incremental hue variation on one side and ...
Medicine Products: